News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
659,253 Results
Type
Article (41068)
Company Profile (191)
Press Release (617994)
Section
Business (187011)
Career Advice (2809)
Deals (34525)
Drug Delivery (105)
Drug Development (77479)
Employer Resources (167)
FDA (16105)
Job Trends (15307)
News (323485)
Policy (31334)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (5)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (3)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (6)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (5)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2694)
Academic (1)
Accelerated approval (1)
Adcomms (23)
Allergies (84)
Alliances (46505)
ALS (93)
Alzheimer's disease (1405)
Antibody-drug conjugate (ADC) (103)
Approvals (16105)
Artificial intelligence (250)
Autoimmune disease (18)
Automation (14)
Bankruptcy (320)
Best Places to Work (12208)
BIOSECURE Act (18)
Biosimilars (100)
Biotechnology (106)
Bladder cancer (60)
Brain cancer (26)
Breast cancer (253)
Cancer (2002)
Cardiovascular disease (168)
Career advice (2338)
Career pathing (32)
CAR-T (144)
Cell therapy (412)
Cervical cancer (17)
Clinical research (62946)
Collaboration (788)
Compensation (456)
Complete response letters (24)
COVID-19 (2551)
CRISPR (42)
C-suite (221)
Cystic fibrosis (104)
Data (1997)
Decentralized trials (1)
Denatured (22)
Depression (39)
Diabetes (246)
Diagnostics (6632)
Digital health (16)
Diversity (4)
Diversity, equity & inclusion (39)
Drug discovery (110)
Drug pricing (102)
Drug shortages (23)
Duchenne muscular dystrophy (85)
Earnings (74254)
Editorial (36)
Employer branding (21)
Employer resources (146)
Events (108198)
Executive appointments (671)
FDA (17232)
Featured Employer (61)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (697)
Gene editing (107)
Generative AI (20)
Gene therapy (296)
GLP-1 (667)
Government (4227)
Grass and pollen (4)
Guidances (45)
Healthcare (19976)
Huntington's disease (20)
IgA nephropathy (23)
Immunology and inflammation (106)
Indications (27)
Infectious disease (2681)
Inflammatory bowel disease (141)
Inflation Reduction Act (9)
Influenza (47)
Intellectual property (91)
Interviews (542)
IPO (16543)
IRA (39)
Job creations (3559)
Job search strategy (1948)
Kidney cancer (10)
Labor market (25)
Layoffs (452)
Leadership (20)
Legal (7299)
Liver cancer (63)
Lung cancer (280)
Lymphoma (127)
Machine learning (4)
Management (62)
Manufacturing (278)
MASH (66)
Medical device (14016)
Medtech (14021)
Mergers & acquisitions (18518)
Metabolic disorders (604)
Multiple sclerosis (68)
NASH (18)
Neurodegenerative disease (90)
Neuropsychiatric disorders (22)
Neuroscience (1899)
NextGen: Class of 2025 (6887)
Non-profit (4840)
Northern California (2472)
Now hiring (28)
Obesity (310)
Opinion (246)
Ovarian cancer (73)
Pain (87)
Pancreatic cancer (75)
Parkinson's disease (140)
Partnered (19)
Patents (211)
Patient recruitment (96)
Peanut (49)
People (55234)
Pharmaceutical (80)
Pharmacy benefit managers (20)
Phase I (19478)
Phase II (27903)
Phase III (20863)
Pipeline (1043)
Podcasts (78)
Policy (109)
Postmarket research (2256)
Preclinical (8094)
Press Release (62)
Prostate cancer (92)
Psychedelics (32)
Radiopharmaceuticals (255)
Rare diseases (378)
Real estate (5467)
Recruiting (67)
Regulatory (21761)
Reports (26)
Research institute (2471)
Resumes & cover letters (453)
Rett syndrome (3)
RNA editing (3)
RSV (40)
Schizophrenia (70)
Series A (118)
Series B (79)
Service/supplier (8)
Sickle cell disease (56)
Southern California (2151)
Special edition (15)
Spinal muscular atrophy (150)
Sponsored (28)
Startups (3322)
State (2)
Stomach cancer (9)
Supply chain (61)
The Weekly (54)
United States (21757)
Vaccines (622)
Venture capitalists (32)
Webinars (10)
Weight loss (196)
Women's health (27)
Worklife (17)
Date
Today (161)
Last 7 days (710)
Last 30 days (2858)
Last 365 days (34817)
2025 (8408)
2024 (36449)
2023 (41626)
2022 (52750)
2021 (57490)
2020 (56081)
2019 (49295)
2018 (37210)
2017 (33230)
2016 (31943)
2015 (37257)
2014 (27816)
2013 (22487)
2012 (23935)
2011 (24646)
2010 (21844)
Location
Africa (833)
Alabama (55)
Alaska (7)
Arizona (165)
Arkansas (12)
Asia (39714)
Australia (6779)
California (5615)
Canada (1884)
China (489)
Colorado (255)
Connecticut (272)
Delaware (131)
Europe (88366)
Florida (839)
Georgia (205)
Idaho (59)
Illinois (523)
India (21)
Indiana (303)
Iowa (8)
Japan (141)
Kansas (98)
Kentucky (26)
Louisiana (7)
Maine (68)
Maryland (835)
Massachusetts (4351)
Michigan (231)
Minnesota (376)
Mississippi (2)
Missouri (83)
Montana (31)
Nebraska (25)
Nevada (57)
New Hampshire (68)
New Jersey (1618)
New Mexico (30)
New York (1614)
North Carolina (981)
North Dakota (8)
Northern California (2472)
Ohio (200)
Oklahoma (14)
Oregon (36)
Pennsylvania (1274)
Puerto Rico (9)
Rhode Island (27)
South America (1189)
South Carolina (19)
South Dakota (1)
Southern California (2151)
Tennessee (94)
Texas (840)
Utah (175)
Virginia (139)
Washington D.C. (57)
Washington State (530)
West Virginia (3)
Wisconsin (54)
659,253 Results for "index pharmaceuticals ab".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Conduit Pharmaceuticals to Join Russell 3000® Index
Conduit Pharmaceuticals Inc., announced the Company is set to join the broad-market Russell 3000® Index at the conclusion of the 2024 Russell US Indexes annual reconstitution, effective at the open of US equity markets on Monday, July 1, 2024, according to a preliminary list of additions posted by FTSE Russell on Friday, May 24th, 2024.
June 13, 2024
·
5 min read
Avadel Pharmaceuticals to Join Russell 3000® Index - June 27, 2024
Avadel Pharmaceuticals plc announced that it is set to join the broad-market Russell 3000® Index at the conclusion of the 2024 Russell US Indexes annual reconstitution, effective at the open of US equity markets on Monday, July 1, 2024, according to a preliminary list of additions posted Friday, May 24, 2024.
June 27, 2024
·
3 min read
InDex Pharmaceuticals announces expected cash balance per March 31, 2024
InDex Pharmaceuticals Holding AB announced that remaining commitments for the company have been quantified, and the expected cash balance per March 31, 2024, amounts to SEK 180-190 million.
January 19, 2024
·
2 min read
InDex Pharmaceuticals is attending the UEGW 2023 congress
InDex Pharmaceuticals Holding AB will attend the United European Gastroenterology Week, one of the world’s leading gastroenterology congresses.
October 5, 2023
·
4 min read
Drug Development
InDex Pharmaceuticals discontinues cobitolimod phase III program
InDex Pharmaceuticals Holding AB announces that an independent DMC has completed the planned dose selection analysis including safety review and assessment for futility in Induction Study 1 of the phase III program CONCLUDE.
November 21, 2023
·
3 min read
ChromaDex to Join Russell 2000® Index
ChromaDex Corp., the global authority on nicotinamide adenine dinucleotide research with a focus on healthy aging, announced its inclusion in the Russell 2000® Index as part of the annual reconstitution of the Russell stock indexes.
July 1, 2024
·
6 min read
Invivyd Announces its Addition to the Russell 2000® and Russell 3000® Indexes
Invivyd, Inc., a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, announced that as part of the annual reconstitution of the Russell stock indexes, Invivyd will be included in the Russell 2000® Index and the broad-market Russell 3000® Index, effective at the open of U.S. equity markets.
July 1, 2024
·
1 min read
InDex Pharmaceuticals has been granted a new patent for cobitolimod in South Korea
InDex Pharmaceuticals Holding AB (publ) today announced that a new method of use patent for the drug candidate cobitolimod has been granted by the Korean Intellectual Property Office.
October 20, 2023
·
1 min read
INOVIO Added to Russell 2000® Index Effective July 1, 2024
INOVIO announced its inclusion in the Russell 2000® Index as part of the annual reconstitution of the Russell stock indexes.
July 1, 2024
·
3 min read
Aileron Therapeutics to be Included in the Russell Microcap® Index
Aileron Therapeutics, Inc. announced that the Company is set to join the Russell Microcap® Index at the conclusion of the 2024 Russell U.S. Indexes annual reconstitution, effective at the open of US equity markets on Monday, July 1, 2024.
July 1, 2024
·
3 min read
1 of 65,926
Next
